zhenhai yu

Dr. zhenhai yu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2018 in Oncogene
Verified
Journal Article
Open access
PDF file
TYTingting Yang
Tingting Yang
CRChune Ren
Chune Ren
PQPengyun Qiao
Pengyun Qiao
XHXue Han
Xue Han
LWLi Wang
Li Wang
ZYzhenhai yu
zhenhai yu
Hexokinase-II (HK2) is a key enzyme involved in glycolysis, which is required for breast cancer progression. However, the underlying post-translational mechanisms of HK2 activity are poorly understood. Here, we showed that Proviral Insertion in Murine Lymphomas 2 (PIM2) directly bound to HK2 and phosphorylated HK2 on Thr473. Biochemical analyses demonstrated that phosphorylated HK2 Thr473 promoted its protein stability through the chaperone-mediated autophagy (CMA) pathway, and the levels of PIM2 and pThr473-HK2 proteins were positively correlated with each other in human breast cancer. Furthermore, phosphorylation of HK2 on Thr473 increased HK2 enzyme activity and glycolysis, and enhanced glucose starvation-induced autophagy. As a result, phosphorylated HK2 Thr473 promoted breast cancer cell growth in vitro and in vivo. Interestingly, PIM2 kinase inhibitor SMI-4a could abrogate the effects of phosphorylated HK2 Thr473 on paclitaxel resistance in vitro and in vivo. Taken together, our findings indicated that PIM2 was a novel regulator of HK2, and suggested a new strategy to treat breast cancer.

31 August 2021 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
CRChune Ren
Chune Ren
XHXue Han
Xue Han
CLChao Lu
Chao Lu
TYTingting Yang
Tingting Yang
PQPengyun Qiao
Pengyun Qiao
ZYzhenhai yu
zhenhai yu

16 March 2022 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
XHXue Han
Xue Han
CRChune Ren
Chune Ren
CLChao Lu
Chao Lu
PQPengyun Qiao
Pengyun Qiao
TYTingting Yang
Tingting Yang
ZYzhenhai yu
zhenhai yu

1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
QFQi Fu
Qi Fu
ZYzhenhai yu
zhenhai yu

15 October 2019 in Cancer Research
Verified
Journal Article
Closed access
TYTingting Yang
Tingting Yang
CRChune Ren
Chune Ren
CLChao Lu
Chao Lu
PQPengyun Qiao
Pengyun Qiao
XHXue Han
Xue Han
ZYzhenhai yu
zhenhai yu
Heat shock transcription factor 1 (HSF1) is the master regulator of the proteotoxic stress response, which plays a key role in breast cancer tumorigenesis. However, the mechanisms underlying regulation of HSF1 protein stability are still unclear. Here, we show that HSF1 protein stability is regulated by PIM2-mediated phosphorylation of HSF1 at Thr120, which disrupts the binding of HSF1 to the E3 ubiquitin ligase FBXW7. In addition, HSF1 Thr120 phosphorylation promoted proteostasis and carboplatin-induced autophagy. Interestingly, HSF1 Thr120 phosphorylation induced HSF1 binding to the PD-L1 promoter and enhanced PD-L1 expression. Furthermore, HSF1 Thr120 phosphorylation promoted breast cancer tumorigenesis in vitro and in vivo. PIM2, pThr120-HSF1, and PD-L1 expression positively correlated with each other in breast cancer tissues. Collectively, these findings identify PIM2-mediated HSF1 phosphorylation at Thr120 as an essential mechanism that regulates breast tumor growth and potential therapeutic target for breast cancer. Significance: These findings identify heat shock transcription factor 1 as a new substrate for PIM2 kinase and establish its role in breast tumor progression.

29 April 2023 in Apoptosis
Verified
Journal Article
Closed access
PDF file
JLJiayi Lu
Jiayi Lu
XLXi Ling
Xi Ling
YSYonghong Sun
Yonghong Sun
LLLu Liu
Lu Liu
LLLan Liu
Lan Liu
ZYzhenhai yu
zhenhai yu